Skip to content
AI IntelligenceJun 18, 2026Primary Market
Article

bioAffinity Technologies, Inc. · Not disclosed · Unbekannt

bioAffinity Technologies has entered into a material definitive agreement, indicating a potential financing or partnership. The company develops non-invasive diagnostics for cancer.

Data Cube AI EditorialSource: SEC EDGAR
01

Source Brief

bioAffinity Technologies has entered into a material definitive agreement, indicating a potential financing or partnership. The company develops non-invasive diagnostics for cancer.